文献速递其他结缔组织病

危重系统性硬化症患者死亡率的临床预测因素:6年回顾性队列研究

Clinical predictors of mortality in critically ill systemic sclerosis patients: a 6-year retrospective cohort study.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

该研究回顾性分析了2016至2021年79例ICU收治的系统性硬化症(SSc)患者,28天死亡率为39.2%(95%CI 28.4-50.9)。较高的改良Rodnan皮肤评分、入ICU时较高的SOFA评分及肺动脉高压相关右心衰竭与28天死亡率升高相关。

要点

  • 危重SSc患者28天死亡率为39.2%。
  • 改良Rodnan皮肤评分越高,28天死亡风险越高(HR 1.11)。
  • 肺动脉高压相关右心衰竭与死亡风险显著相关(HR 10.2)。

核心结论

  • 危重SSc患者28天死亡率升高与较高的改良Rodnan皮肤评分、入ICU时较高的SOFA评分及肺动脉高压相关右心衰竭显著相关。

研究设计与样本

  • 回顾性队列研究,纳入2016至2021年ICU收治的SSc患者,共79例ICU入住记录,收集门诊及ICU入院数据。

主要发现

  • 79例ICU入住中,弥漫性皮肤型SSc 65例(82.3%),间质性肺病65例(82%),肺动脉高压31例(39.2%),心脏受累20例(25.3%)。
  • ICU入住主要原因包括肺炎(29.1%)、心力衰竭(26.6%)和感染性休克(15.2%)。
  • SSc特异性活动性器官受累包括活动性心肌炎(25.3%)、肾危象(13.9%)、间质性肺病进展(7.6%)及肺动脉高压相关右心衰竭(6.3%)。
  • 28天死亡率为39.2%(95%CI 28.4-50.9)。
  • 较高死亡率与较高改良Rodnan皮肤评分(HR 1.11,95%CI 1.06-1.16)、入ICU时较高SOFA评分(HR 1.28,95%CI 1.16-1.41)及肺动脉高压相关右心衰竭(HR 10.2,95%CI 2.93-35.2)相关。

临床怎么用

  • 对危重SSc患者应评估改良Rodnan皮肤评分、入ICU时SOFA评分及肺动脉高压相关右心衰竭以识别高死亡风险者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study examines clinical predictors of 28-day mortality in critically ill systemic sclerosis (SSc) patients. METHODS: A retrospective cohort study was conducted on SSc patients in the ICU from 2016 to 2021. Data was gathered on both outpatient and ICU admissions. The primary outcome was 28-day mortality, with secondary outcomes including the incidence of acute complications and organ failure during hospitalization. RESULTS: In a total of 79 ICU admissions for SSc, diffuse cutaneous SSc was identified in 65 patients (82.3%). Of these, 65 (82%) had interstitial lung disease (ILD), 31 (39.2%) had pulmonary hypertension and 20 (25.3%) had cardiac involvement. Leading causes for ICU admission were pneumonia (29.1%), heart failure (26.6%) and septic shock (15.2%). Active organ involvement specific to SSc included active carditis (25.3%), renal crisis (13.9%), ILD progression (7.6%) and pulmonary hypertension associated with right ventricular (RV) failure (6.3%). The 28-day mortality rate was 39.2% (95%CI 28.4-50.9). The higher mortality rate was associated with a higher modified Rodnan skin score (HR 1.11, 95%CI 1.06-1.16), higher SOFA score at ICU admission (HR 1.28, 95%CI 1.16-1.41) and pulmonary hypertension-associated RV failure (HR 10.2, 95%CI 2.93-35.2). CONCLUSION: Increased 28-day mortality in critically ill SSc patients is notably linked with higher modified Rodnan skin score and SOFA score at ICU admission, as well as pulmonary hypertension-related right ventricular failure.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Wattanarat B, Foocharoen C, Panitchote A, et al. Clinical predictors of mortality in critically ill systemic sclerosis patients: a 6-year retrospective cohort study. Rheumatology (Oxford). 2026. PMID: 41507092. doi:10.1093/rheumatology/keag008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。